Endocrine Abstracts

Aim: The aim of this study is evaluating trabecular bone score (TBS) and bone mineral density (BMD) in normal women depending on duration of postmenopausal period (PMP).Materials and methods: We’ve examined 122 normal women aged 40–79 years (mean age – 56.2±0.8 years; mean height – 162.6±0.5 cm; mean weight – 71.5±1.3 kg), who were divided into the groups depending on duration of PMP: without menopause (with normal...

Aim: The aim of this study is evaluating of body composition and frequency of sarcopenia in women depending on age.Materials and methods: We’ve examined 8637 women aged 20–89 years (mean age – 56.7±0.14 years; mean height – 162.5±0.07 cm; mean weight – 73.5±0.16 kg). The patients were divided into two groups depending on age: 20–24 (n=143), 25–29 (n=209), 30–34 (n=271), 35&...

Aim: To evaluate the effect of strontium ranelate in treatment of systemic osteoporosis in postmenopausal women.Materials and methods: There were examined 82 postmenopausal women with systemic osteoporosis (average age 58.4±4.5 years). Evaluation of pain syndrome and level of physical activity was carried out with VAS (the questionnaire developed by the ‘Servier’ company). Bone mineral density (BMD) was determined by means of dual-energy X...

Objective: The metabolic syndrome (MS), which includes obesity, dyslipidemia, impaired glucose tolerance, and hypertension, is a major public health problem. The prevalence of MS among women in postmenopausal period is nearly 24%. In postmenopausal period the accelerated bone loss, contributing to the development of osteoporosis begins. Obesity or increased body mass index (BMI) is known to have a protective effect against osteoporosis. However, recent studies demonstrated tha...